Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+11.76%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$56.8B
AUM Growth
+$7.38B
(+15%)
Cap. Flow
+$2.83B
Cap. Flow
% of AUM
4.98%
Top 10 Holdings %
Top 10 Hldgs %
27.76%
Holding
1,604
New
60
Increased
723
Reduced
255
Closed
38
Top Buys
| 1 |
Procter & Gamble
PG
|
+$205M |
| 2 |
Philip Morris
PM
|
+$203M |
| 3 |
Microsoft
MSFT
|
+$198M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$158M |
| 5 |
Coca-Cola
KO
|
+$144M |
Top Sells
| 1 |
PayPal
PYPL
|
+$223M |
| 2 |
Accenture
ACN
|
+$179M |
| 3 |
Adobe
ADBE
|
+$148M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$64M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$62.7M |
Sector Composition
| 1 | Technology | 29.07% |
| 2 | Healthcare | 15.55% |
| 3 | Financials | 13.39% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Consumer Staples | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Marathon Digital Holdings
MARA
$5.88B
| $282K | ﹤0.01% |
12,038
-7,494
| -38% | -$176K |
|
977
Krystal Biotech
KRYS
$3.98B
| $279K | ﹤0.01% |
2,345
-662
| -22% | -$78.7K |
|
978
Arrowhead Research
ARWR
$3.99B
| $279K | ﹤0.01% |
8,714
+952
| +12% | +$30.4K |
|
979
Xencor
XNCR
$596M
| $278K | ﹤0.01% |
12,725
+2,378
| +23% | +$52K |
|
|
BITF
980
Bitfarms
BITF
$967M
| $278K | ﹤0.01% |
98,880
+509
| +0.5% | +$1.43K |
|
981
BioNTech
BNTX
$24.3B
| $274K | ﹤0.01% |
2,487
-238
| -9% | -$26.2K |
|
|
LAND
982
Gladstone Land Corp
LAND
$321M
| $273K | ﹤0.01% |
19,400
| – | – |
|
983
Novartis
NVS
$245B
| $270K | ﹤0.01% |
2,580
+585
| +29% | +$61.3K |
|
|
ALX
984
Alexander's
ALX
$1.22B
| $260K | ﹤0.01% |
1,205
| – | – |
|
|
VERV
985
DELISTED
Verve Therapeutics
VERV
| $258K | ﹤0.01% |
19,884
+3,405
| +21% | +$44.3K |
|
986
Vir Biotechnology
VIR
$713M
| $253K | ﹤0.01% |
25,078
+14,271
| +132% | +$144K |
|
987
Recursion Pharmaceuticals
RXRX
$1.98B
| $252K | ﹤0.01% |
26,055
-6,947
| -21% | -$67.3K |
|
988
Ginkgo Bioworks
DNA
$609M
| $247K | ﹤0.01% |
4,016
-1,610
| -29% | -$99.2K |
|
989
Rocket Companies
RKT
$44B
| $243K | ﹤0.01% |
18,213
-3,300
| -15% | -$44K |
|
990
Intellia Therapeutics
NTLA
$1.21B
| $242K | ﹤0.01% |
8,204
+1,553
| +23% | +$45.8K |
|
991
LendingClub
LC
$1.86B
| $235K | ﹤0.01% |
27,761
+9,184
| +49% | +$77.8K |
|
|
FSR
992
DELISTED
Fisker Inc.
FSR
| $235K | ﹤0.01% |
157,661
+49,234
| +45% | +$73.4K |
|
993
ICICI Bank
IBN
$113B
| $233K | ﹤0.01% |
9,800
-2,140
| -18% | -$50.8K |
|
994
BridgeBio Pharma
BBIO
$10.1B
| $231K | ﹤0.01% |
6,113
-9,176
| -60% | -$347K |
|
995
Caribou Biosciences
CRBU
$166M
| $230K | ﹤0.01% |
+44,202
| New | +$230K |
|
|
HUT
996
Hut 8
HUT
$3.27B
| $227K | ﹤0.01% |
18,433
-180
| -1% | -$2.22K |
|
997
AbCellera Biologics
ABCL
$1.28B
| $221K | ﹤0.01% |
38,855
+4,641
| +14% | +$26.5K |
|
998
Roivant Sciences
ROIV
$9.4B
| $221K | ﹤0.01% |
20,311
-1,139
| -5% | -$12.4K |
|
|
OPI
999
Office Properties Income Trust
OPI
$18.7M
| $218K | ﹤0.01% |
31,375
+4,950
| +19% | +$34.4K |
|
1000
CRISPR Therapeutics
CRSP
$4.71B
| $218K | ﹤0.01% |
3,481
-1,003
| -22% | -$62.7K |
|